Inventor · disambiguated record
Simona Cotesta
Also filed as: COTESTA SIMONA
10 granted patents·16 pending applications·16 citations·filing 2008–2022
81Inventor score
Top patents by PatentIndex Score
26 records- 0177US8975417B2Pyrazolopyrrolidine derivatives and their use in the treatment of diseaseBORDAS VINCENT·Filed 2014·Granted Mar 10, 2015·6 cites·24 claims
- 0276US8530648B2Diaza-spiro[5.5]undecanesBADIGER SANGAMESH·Filed 2010·Granted Sep 10, 2013·5 cites·13 claims
- 0370US8742106B2Disubstituted heteroaryl-fused pyridinesBADIGER SANGAMESH·Filed 2010·Granted Jun 3, 2014·3 cites·16 claims
- 0466US9365576B2Pyrrolopyrrolidinone compoundsCOTESTA SIMONA·Filed 2013·Granted Jun 14, 2016·2 cites·12 claims
- 0561US7977323B2C2-C5-alkyl-imidazole-bisphosphonatesNOVARTIS AG·Filed 2008·Granted Jul 12, 2011·0 cites·5 claims
- 0659US2024317721A1Pyrazolyl derivatives as inhibitors of the kras mutant proteinNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0756US2024366567A1Pharmaceutical combinations comprising a kras g12c inhibitor and uses thereof for the treatment of cancersNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0853US2024082218A1Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancersNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0951US2011257131A1Phenylalkyl-imidazole-bisphosphonate compoundsNOVARTIS AG·Filed 2009·Application pending·0 cites
- 1051US2024116900A1New crystalline forms of a kras g12c inhibitor compoundNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1150US11702409B2Pyrazolyl derivatives useful as anti-cancer agentsNOVARTIS AG·Filed 2020·Granted Jul 18, 2023·0 cites·34 claims
- 1248US9624247B2Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of diseaseBLANK JUTTA·Filed 2014·Granted Apr 18, 2017·0 cites·11 claims
- 1348US2012094958A1Quinolines as inhibitors of farnesyl pyrophosphate synthaseAMSTUTZ RENE·Filed 2009·Application pending·0 cites
- 1446US9890166B2Imidazopyrrolidine derivatives and their use in the treatment of diseaseBLANK JUTTA·Filed 2014·Granted Feb 13, 2018·0 cites·13 claims
- 1546US2016095843A1Pyrazolopyrrolidine derivatives and their use in the treatment of diseaseBLANK JUTTA·Filed 2014·Application pending·0 cites
- 1645US2013281463A1Diaza-spiro[5.5]undecanes useful as orexin receptor antagonistsBADIGER SANGAMESH·Filed 2011·Application pending·0 cites
- 1744US2011288057A1Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitorsCOTESTA SIMONA·Filed 2009·Application pending·0 cites
- 1844US2011224173A1C2-C5-Alkyl-Imidazole-BisphosphonatesNOVARTIS AG·Filed 2011·Application pending·0 cites
- 1944US2012101110A1Diaza-spiro[5.5]undecanesBADIGER SANGAMESH·Filed 2011·Application pending·0 cites
- 2041US2009099199A1Organic compoundsNOZULAK JOACHIM·Filed 2008·Application pending·0 cites
- 2140US9714249B2Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of diseaseBLANK JUTTA·Filed 2014·Granted Jul 25, 2017·0 cites·6 claims
- 2239US9550796B2Pyrrolopyrrolone derivatives and their use as BET inhibitorsRUEGER HEINRICH·Filed 2014·Granted Jan 24, 2017·0 cites·13 claims
- 2335US2012165331A1Di/tri-aza-spiro-C9-C11alkanesBADIGER SANGAMESH·Filed 2011·Application pending·0 cites
- 2434US2010222396A14-aryl-butane-1,3-diamidesNOVARTIS AG·Filed 2010·Application pending·0 cites
- 2530US2017088546A1Carboxamide inhibitorsNOVARTIS AG·Filed 2015·Application pending·0 cites
- 2626US2017088545A1Carboxamide inhibitorsNORVARTIS AG·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →